Cover Image

Bispidines for radiopharmaceuticals

Very rigid tetra-, penta-, hexa-, hepta- and octadentate bispidine ligands are well preorganized for specific coordination geometries. The broad range of coordination numbers, geometries and donor sets allows one to design and prepare bispidines for many specific metal ions and applications. Major r...

Full description

Saved in:
Bibliographic Details
Main Authors: Comba, Peter (Author) , Kerscher, Marion (Author) , Rück, Katharina (Author) , Starke, Miriam (Author)
Format: Article (Journal)
Language:English
Published: [2018]
In: Dalton transactions
Year: 2018, Volume: 47, Issue: 28, Pages: 9202-9220
ISSN:1477-9234
DOI:10.1039/C8DT01108G
Online Access:Verlag, Volltext: https://doi.org/10.1039/C8DT01108G
Verlag, Volltext: https://pubs.rsc.org/en/content/articlelanding/2018/dt/c8dt01108g
Get full text
Author Notes:Peter Comba, Marion Kerscher, Katharina Rück and Miriam Starke

MARC

LEADER 00000caa a2200000 c 4500
001 1666591165
003 DE-627
005 20230426220651.0
007 cr uuu---uuuuu
008 190603s2018 xx |||||o 00| ||eng c
024 7 |a 10.1039/C8DT01108G  |2 doi 
035 |a (DE-627)1666591165 
035 |a (DE-599)KXP1666591165 
035 |a (OCoLC)1341225922 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 30  |2 sdnb 
100 1 |a Comba, Peter  |d 1953-  |e VerfasserIn  |0 (DE-588)122976843  |0 (DE-627)082271712  |0 (DE-576)160608988  |4 aut 
245 1 0 |a Bispidines for radiopharmaceuticals  |c Peter Comba, Marion Kerscher, Katharina Rück and Miriam Starke 
264 1 |c [2018] 
300 |b Illustrationen 
300 |a 19 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 03.06.2019 
520 |a Very rigid tetra-, penta-, hexa-, hepta- and octadentate bispidine ligands are well preorganized for specific coordination geometries. The broad range of coordination numbers, geometries and donor sets allows one to design and prepare bispidines for many specific metal ions and applications. Major requirements for radiopharmaceuticals are efficient labeling, inertness under physiological conditions and easy functionalization of the ligands with biological vectors. The reasons why bispidines are among the most favorable chelators for radiopharmaceutical applications, a comprehensive list of bispidine ligands and a range of examples where bispidines have been used to develop radiopharmaceuticals for future applications in diagnosis and therapy are discussed. 
700 1 |a Kerscher, Marion  |e VerfasserIn  |0 (DE-588)1074024087  |0 (DE-627)830169598  |0 (DE-576)187074925  |4 aut 
700 1 |a Rück, Katharina  |e VerfasserIn  |0 (DE-588)1077779852  |0 (DE-627)837498090  |0 (DE-576)446669628  |4 aut 
700 1 |a Starke, Miriam  |e VerfasserIn  |0 (DE-588)1144903262  |0 (DE-627)1005031525  |0 (DE-576)495503606  |4 aut 
773 0 8 |i Enthalten in  |t Dalton transactions  |d Cambridge : Royal Society of Chemistry, 2003  |g 47(2018), 28, Seite 9202-9220  |h Online-Ressource  |w (DE-627)268759146  |w (DE-600)1472887-4  |w (DE-576)077609883  |x 1477-9234  |7 nnas  |a Bispidines for radiopharmaceuticals 
773 1 8 |g volume:47  |g year:2018  |g number:28  |g pages:9202-9220  |g extent:19  |a Bispidines for radiopharmaceuticals 
856 4 0 |u https://doi.org/10.1039/C8DT01108G  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://pubs.rsc.org/en/content/articlelanding/2018/dt/c8dt01108g  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20190603 
993 |a Article 
994 |a 2018 
998 |g 1144903262  |a Starke, Miriam  |m 1144903262:Starke, Miriam  |d 120000  |d 120200  |e 120000PS1144903262  |e 120200PS1144903262  |k 0/120000/  |k 1/120000/120200/  |p 4  |y j 
998 |g 1077779852  |a Rück, Katharina  |m 1077779852:Rück, Katharina  |d 120000  |d 120200  |e 120000PR1077779852  |e 120200PR1077779852  |k 0/120000/  |k 1/120000/120200/  |p 3 
998 |g 1074024087  |a Kerscher, Marion  |m 1074024087:Kerscher, Marion  |d 120000  |d 120200  |e 120000PK1074024087  |e 120200PK1074024087  |k 0/120000/  |k 1/120000/120200/  |p 2 
998 |g 122976843  |a Comba, Peter  |m 122976843:Comba, Peter  |d 120000  |d 120200  |e 120000PC122976843  |e 120200PC122976843  |k 0/120000/  |k 1/120000/120200/  |p 1  |x j 
999 |a KXP-PPN1666591165  |e 3480721001 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Peter Comba, Marion Kerscher, Katharina Rück and Miriam Starke"]},"recId":"1666591165","note":["Gesehen am 03.06.2019"],"title":[{"title_sort":"Bispidines for radiopharmaceuticals","title":"Bispidines for radiopharmaceuticals"}],"person":[{"role":"aut","display":"Comba, Peter","family":"Comba","given":"Peter"},{"role":"aut","family":"Kerscher","display":"Kerscher, Marion","given":"Marion"},{"role":"aut","display":"Rück, Katharina","family":"Rück","given":"Katharina"},{"role":"aut","given":"Miriam","display":"Starke, Miriam","family":"Starke"}],"physDesc":[{"extent":"19 S.","noteIll":"Illustrationen"}],"relHost":[{"disp":"Bispidines for radiopharmaceuticalsDalton transactions","name":{"displayForm":["Royal Society of Chemistry"]},"note":["Gesehen am 30.01.25"],"pubHistory":["2003, issue 1 (2003)-"],"recId":"268759146","origin":[{"publisher":"Royal Society of Chemistry","dateIssuedKey":"2003","publisherPlace":"Cambridge","dateIssuedDisp":"2003-"}],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"subtitle":"a journal of inorganic chemistry, including bioinorganic, organometallic, and solid-state chemistry","title":"Dalton transactions","title_sort":"Dalton transactions"}],"part":{"volume":"47","text":"47(2018), 28, Seite 9202-9220","pages":"9202-9220","extent":"19","year":"2018","issue":"28"},"type":{"media":"Online-Ressource","bibl":"periodical"},"corporate":[{"role":"isb","display":"Royal Society of Chemistry"}],"language":["eng"],"id":{"eki":["268759146"],"issn":["1477-9234"],"zdb":["1472887-4"]}}],"language":["eng"],"id":{"eki":["1666591165"],"doi":["10.1039/C8DT01108G"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedKey":"2018","dateIssuedDisp":"[2018]"}]} 
SRT |a COMBAPETERBISPIDINES2018 

Similar Items